title: Protection of Neonatal Broiler Chickens Following in ovo Delivery of Oligodeoxynucleotides Containing CpG Motifs (CpG-ODN) Formulated with Carbon Nanotubes or Liposomes.
abstract: Unformulated oligodeoxynucleotides (ODN) containing CpG motifs (CpG-ODN) have been shown to stimulate the innate immune system against a variety of bacterial, viral, and protozoan infections in a variety of vertebrate species. We have previously shown that in ovo delivery of unformulated CpG-ODN was able to significantly protect neonatal broiler chickens against Escherichia coli or Salmonella Typhimurium infections. The objectives of this study were to examine the safety and immunoprotective effects of CpG-ODN formulated with 2 types of carbon nanotubes (CNTs) or 2 types of lipid-surfactant (LSC) delivery systems in neonatal broilers against E. coli septicemia. Embryonated eggs, which had been incubated for 18 days, received either 50 μg of CNT-CpG-ODN, 50 μg of LSC-CpG-ODN, 50 μg of unformulated CpG-ODN, or saline. Four days after exposure to CpG-ODN (day 1 posthatch), 1 x 10(4) or 1 x 10(5) colony-forming units of a virulent strain of E. coli isolated from a turkey with septicemia were inoculated subcutaneously in the neck. Clinical signs, pathology, bacterial isolations from the air sacs, and mortality were observed for 8 days following challenge with E. coli. Bacterial isolations and pathologic observations were conducted immediately after birds were dead or euthanatized. The survival rate of birds in groups receiving saline following E. coli infection was 20% to 30%. In contrast, birds receiving CpG-ODN formulations had a significantly higher survival rate of 60% to 80% (P < 0.01). Bacterial loads and clinical scores were significantly lower (P < 0.05) in groups treated with CNT- or LSC-CpG-ODN compared to the groups receiving CpG-ODN or saline. Moreover, there is no evidence of any adverse effects of these formulations in any organs or in growth rates of birds until 42 days of age. This is the first time that CpG-ODN formulated with CNT and LSC have been demonstrated to have an immunomodulatory effect against an E. coli infection in neonatal broiler chickens following in ovo delivery.
authors: Thushari
authors: T
authors: Gunawardana
authors: Marianna
authors: M
authors: Foldvari
authors: Tara
authors: T
authors: Zachar
authors: Shelly
authors: S
authors: Popowich
authors: Betty
authors: B
authors: Chow-Lockerbie
authors: Marina Vaneva
authors: MV
authors: Ivanova
authors: Suresh
authors: S
authors: Tikoo
authors: Shanika
authors: S
authors: Kurukulasuriya
authors: Philip
authors: P
authors: Willson
authors: Susantha
authors: S
authors: Gomis
mesh_terms: D000818:Animals; D002645:Chickens; D004927:Escherichia coli Infections / Q000517:prevention & control / Q000662:veterinary*; D008081:Liposomes; D037742:Nanotubes, Carbon; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000494:pharmacology*; D010063:Ovum; D011201:Poultry Diseases / Q000517:prevention & control
chemical_list: D008081:Liposomes; D037742:Nanotubes, Carbon; D009838:Oligodeoxyribonucleotides